These past few months have been a rush of fresh air. Aimovig. The drug we’d all been waiting for, was approved by the FDA. Now a few months later, we have Ajovy and Emgality in the mix as well. For a brief background, new research has pointed to CGRP being a main inhibitor for migraines, […]